Total Payments
$31,927
2024 Payments
$295.71
Companies
17
Transactions
97
Medicare Patients
11,666
Medicare Billing
$14.1M
Payment Breakdown by Category
Other$28,756 (90.1%)
Food & Beverage$3,152 (9.9%)
Gifts$19.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $16,629 | 1 | 52.1% |
| Current or prospective ownership or investment interest | $11,986 | 6 | 37.5% |
| Food and Beverage | $3,152 | 79 | 9.9% |
| Honoraria | $141.07 | 4 | 0.4% |
| Gift | $19.40 | 1 | 0.1% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$31,927
91 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $28,615 | 13 | $0 (2022) |
| Genentech USA, Inc. | $940.38 | 30 | $0 (2023) |
| Allergan, Inc. | $481.63 | 15 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $472.63 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $312.60 | 6 | $0 (2020) |
| ABBVIE INC. | $166.88 | 9 | $0 (2024) |
| NotalVision | $141.07 | 4 | $0 (2017) |
| Alcon Vision LLC | $129.71 | 1 | $0 (2021) |
| Biogen, Inc. | $115.33 | 2 | $0 (2023) |
| Alcon Laboratories Inc | $112.09 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $295.71 | 8 | Regeneron Healthcare Solutions, Inc. ($198.20) |
| 2023 | $185.18 | 9 | AbbVie Inc. ($70.19) |
| 2022 | $21,853 | 25 | US Retina LLC ($21,276) |
| 2021 | $4,217 | 7 | US Retina LLC ($4,000) |
| 2020 | $1,525 | 6 | US Retina LLC ($1,445) |
| 2019 | $2,443 | 15 | US Retina LLC ($1,895) |
| 2018 | $389.14 | 7 | Genentech USA, Inc. ($126.25) |
| 2017 | $1,019 | 20 | Genentech USA, Inc. ($370.86) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: EYE CARE | ||||||
| 04/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Ophthalmology | ||||||
| 03/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $123.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: EYE CARE | ||||||
| 01/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: EYE CARE | ||||||
| 12/11/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/21/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $33.00 | General |
| 09/26/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $32.99 | General |
| 08/16/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: EYE CARE | ||||||
| 04/26/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: EYE CARE | ||||||
| 02/22/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: EYE CARE | ||||||
| 02/08/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 01/23/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/17/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: EYE CARE | ||||||
| 12/20/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/20/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/20/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/08/2022 | Genentech USA, Inc. | Lucentis (Biological), VABYSMO | Food and Beverage | In-kind items and services | $145.90 | General |
| Category: Ophthalmology | ||||||
| 11/14/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/14/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/09/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $97.66 | General |
| 11/03/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,993 | 24,714 | $8.3M | $3.5M |
| 2022 | 19 | 2,870 | 14,976 | $7.4M | $3.4M |
| 2021 | 16 | 2,916 | 11,901 | $7.4M | $3.5M |
| 2020 | 19 | 2,887 | 12,427 | $7.7M | $3.6M |
Total Patients
11,666
Total Services
64,018
Medicare Billing
$14.1M
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 211 | 3,312 | $4.1M | $2.3M | 55.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 19 | 13,080 | $555,900 | $381,069 | 68.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 308 | 1,930 | $1.3M | $181,087 | 13.9% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 23 | 890 | $391,600 | $153,581 | 39.2% |
| J3490 | Unclassified drugs | Office | 2023 | 14 | 49 | $432,500 | $116,670 | 27.0% |
| J3590 | Unclassified biologics | Office | 2023 | 27 | 36 | $426,000 | $101,748 | 23.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 17 | 495 | $247,500 | $90,664 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 677 | 1,178 | $206,150 | $70,344 | 34.1% |
| 92134 | Imaging of retina | Office | 2023 | 358 | 1,511 | $151,100 | $42,905 | 28.4% |
| 92250 | Photography of the retina | Office | 2023 | 783 | 1,319 | $197,850 | $33,079 | 16.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 11 | 112 | $30,800 | $17,722 | 57.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 158 | 169 | $42,250 | $16,455 | 38.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 43 | 168 | $16,800 | $8,831 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 102 | $25,500 | $8,775 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 99 | 99 | $21,285 | $7,041 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $18,585 | $6,261 | 33.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 24 | 29 | $43,500 | $4,997 | 11.5% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 12 | 13 | $19,500 | $4,814 | 24.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 21 | $4,515 | $722.22 | 16.0% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 14 | 17 | $2,550 | $616.12 | 24.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 14 | 17 | $1,700 | $298.90 | 17.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 108 | $540.00 | $85.07 | 15.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 210 | 3,410 | $4.3M | $2.4M | 57.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 49 | 1,908 | $954,000 | $416,221 | 43.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 293 | 1,901 | $1.3M | $177,251 | 13.8% |
About Dr. John Thordsen, MD
Dr. John Thordsen, MD is a Ophthalmology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073659769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Thordsen, MD has received a total of $31,927 in payments from pharmaceutical and medical device companies, with $295.71 received in 2024. These payments were reported across 97 transactions from 17 companies. The most common payment nature is "Acquisitions" ($16,629).
As a Medicare-enrolled provider, Thordsen has provided services to 11,666 Medicare beneficiaries, totaling 64,018 services with total Medicare billing of $14.1M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Raleigh, NC
- Active Since 01/29/2007
- Last Updated 09/24/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1073659769
Products in Payments
- Lucentis (Biological) $693.24
- OZURDEX (Drug) $648.51
- VABYSMO (Drug) $210.41
- EYLEA (Biological) $201.31
- EYLEA HD (Biological) $146.33
- ForeseeHome (Device) $141.07
- AcrySof IQ VIVITY IOL (Device) $129.71
- EYLEA AFLIBERCEPT INJECTION (Biological) $124.99
- ACTIVEFOCUS (Device) $112.09
- VYZULTA (Drug) $101.24
- Bromsite (Drug) $100.00
- SUSVIMO (Drug) $73.65
- BEOVU (Drug) $64.39
- Izervay (Drug) $33.25
- Vabysmo (Drug) $31.33
- None Specified (Medical Supply) $19.40
- Iluvien (Biological) $12.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Raleigh
Preeya Gupta, Md, MD
Ophthalmology — Payments: $1.7M
Ophthalmology $1.7M
Dr. Daniel Bennett, Md, MD
Ophthalmology — Payments: $149,562
Ophthalmology $149,562
Raynor Casey, M.d, M.D
Ophthalmology — Payments: $35,026
Ophthalmology $35,026
Sachin Mudvari, Md, MD
Ophthalmology — Payments: $33,257
Ophthalmology $33,257
Isaac Porter, M.d, M.D
Ophthalmology — Payments: $9,542
Ophthalmology $9,542
Dr. Nitin Gupta, M.d., M.p.h, M.D., M.P.H
Ophthalmology — Payments: $8,730
Ophthalmology $8,730